Partnership

How a decades-long friendship between two Vancouver executives led to a major strategic deal, a new $500M fund, and a plan to thrive in tech's chaotic market.

The venture firm's largest fund yet isn't just a big number; it's a bet on a fundamental rewrite of how value and liquidity work in a world beyond the IPO.

A landmark deal between Boston Globe Media and Freestar reveals a new strategy for publishers: focusing on journalism by letting ad tech experts run monetization.

A new pilot pairs a finance giant with a crypto network to solve the biggest hurdle for digital assets: scalable compliance. Is this the key to unlocking global stablecoin adoption?

ASDS's new retreat isn't just education; it’s a strategic signal that for modern doctors, financial and tech literacy are now as vital as clinical skill.

Soprano Eleonora Buratto lends her voice to fight 'butterfly disease,' highlighting an innovative venture philanthropy model rewriting the playbook for rare illnesses.

e& UAE deploys Ciena's groundbreaking 1.6Tb/s optical tech, building a future-ready network to power the Middle East's AI and hyperscale ambitions.

As Culver's expands at a breakneck pace, its new partnership with Armada reveals a critical lesson: the future of foodservice is won in the warehouse.

Bristol Myers Squibb's large-scale deployment of Schrödinger's Bunsen AI isn't just a software deal; it's a strategic signal for the future of pharma R&D.

A new leaderboard on DefiLlama finally lets traders see how well market makers perform, adding a crucial new layer of data for judging a token's health.

Lifeward's pilot program with Ottobock Care isn't just a deal; it’s a strategic blueprint for scaling advanced medical tech in a new era of reimbursement.

A new partnership uses smartphone AI to turn everyday movement into a vital sign, aiming to predict falls, manage chronic illness, and remake home healthcare.

While many chase AI headlines, 3PL giant Kenco is rewriting its operational DNA with DeepFabric's 'agentic AI,' deploying bots at record speed.

A quiet South Korean biotech is shaking up the drug delivery landscape. Alteogen's latest deal signals a major shift as Big Pharma races to make treatments better.

AI is no longer just a chatbot. Autonomous agents are now handling real work, creating massive security gaps. A new partnership aims to make them visible.

Eton Pharmaceuticals' new deal for ASN-001 is more than a pipeline buy; it's a calculated maneuver to capture the entire infantile hemangioma treatment space.

An Indianapolis health system's deal with AI firm Clarium reveals a critical new front in healthcare's war on waste: the operating room supply chain.

As Everest Medicines preps its H1 2026 results, investors are watching for more than just profit, focusing on its pivot to a global innovation engine.

Éric Scotto, the force behind Akuo Energy, joins Pont Digital Infrastructure to solve the data industry's energy crisis. Can his green playbook work?

MasterCraft's pontoon brands are integrating Apple CarPlay with Savvy Navvy. We analyze the strategy, the execution, and what it means for the industry.